The University of Manchester has been successfully awarded a share of the £79 million committed by the Medical Research Council to support doctoral training.
The bid was co-ordinated by Dr Anna Woollams from the University’s Faculty of Biology, Medicine and Health.
The Medical Research Council award is part of a drive to support high-quality doctoral training programmes that take a student-centred approach, focusing on scientific excellence, positive research culture and wider training opportunities.
This investment from the MRC, plus significant matched funding contribution from the University, will fund standard and CASE 4-year studentships over three annual cohorts starting in October 2022, with an additional two intake years subject to a mid-term review.
Research within the DTP will be focused on themes relating to Disease Mechanisms, Detection & Diagnosis, and Developing Interventions.
Projects will be complemented by an innovative programme of bespoke training in transferrable skills with additional opportunities for individualised training, including placements, internships and collaborating with industry. The Manchester DTP includes associate partners Bionow, Alderley Park and Medicines Discovery Catapult.
Professor Melissa Westwood, Associate Vice-President for Research commented: ‘I am extremely proud of the achievement of the PGRs from our current cohorts both in terms of their research impact and their contribution to our culture and environment. I am really looking forward to welcoming more PGRs to the new programme, designed to achieve not only excellent scientific research, but innovation in industry and impact on society, which will enable them to move on to a diverse set of career directions and become our research leaders of the future.”
Recruitment to the 2022 studentships will be underway soon.